Skip to content

Clinical trials

Phase 1/2 Carcinoma, Hepatocellular trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1/2 Country / region: United States Clear all

101 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20021
20032
20042
20051
20062
20072
20081
20093
20101
20114
20123
20133
20147
20152
20165
20177
20184
20196
20201
20215
20229
20238
20243
20256
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Recruiting26
Terminated18
Withdrawn7
Active, not recruiting5
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
M.D. Anderson Cancer Center4
Bristol-Myers Squibb3
Eisai Inc.3
Incyte Biosciences International Sàrl3
AstraZeneca2
Celgene2
Eli Lilly and Company2
Eureka Therapeutics Inc.2
Jonsson Comprehensive Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular101
Liver Neoplasms30
Colorectal Neoplasms20
Melanoma16
Carcinoma, Non-Small-Cell Lung14
Carcinoma, Renal Cell12
Neoplasms12
Endometrial Neoplasms11
Neoplasm Metastasis10
Ovarian Neoplasms10

Trials

Showing 1 to 25 of 101. Each trial links to its page on Pharma Observatory.

1 more trial matches. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.